跳至主要内容
临床试验/IRCT20210622051660N1
IRCT20210622051660N1招募中3 期

Evaluation of the effect of adding Gaznab herbal product to standard treatment in patients with primary hypertension compared to placebo

Mashhad University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • Men and women aged 30-65 years
  • Hypertension grade1 with pressure equal to or greater than 140.90 mmHg to 159.99 mmHg
  • Are treated with a blood pressure medication (one to three drugs based on the protocol).
  • BMI greater than or equal to 27
  • At least one month has passed since starting the medication
  • The person should not be at high risk (diabetes mellitus and end organ damage , etc.)

排除标准

  • History of hypo or hyperthyroidism
  • Types of cardiac dysrhythmias (such as second and third degree block)
  • Allergy to medicinal plants
  • History of potassium greater than 5.1 or less than 3.5 m Eq / L at the first visit
  • Warfarin consumption
  • Pregnancy or lactation
  • History of hypermenorrhea in females
  • Presence of blood pressure greater than or equal to 180/110 mm Hg
  • The presence of any medical or surgical disorder that could interfere with the study.

研究者

相似试验